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Entamoeba histolytica is the causative agent of amoebiasis. During infection, the actively 19 replicating trophozoite (amoeba) form colonizes the large intestine. Symptoms range from 20 asymptomatic infection, diarrhea, bloody diarrhea, to fatal extraintestinal abscesses. The species 21 name (histo-: tissue; lytic-: dissolve) refers to the capacity of the amoeba to damage human 22 tissues. However, it is still unclear how amoebae invade and damage tissues. Virulence factors 23 include the amoeba surface galactose and N-acetylgalactosamine (Gal/GalNAc)-inhibitable 24 lectin that mediates attachment to human cells and other substrates (Petri, 2002) and cysteine 25 proteases that degrade a variety of human substrates (e.g., Reed, 1995 , Lidell, 2006 , Thibeaux, 26 2012 ). In addition to these factors, the contact-dependent human-cell killing activity of E. 27 histolytica (Ravdin, 1980a , Ravdin, 1981 is likely to be a major contributor to human tissue 28 damage. 29
While it has been under investigation for many years, the mechanism by which amoebae 30 kill human cells was previously unclear (Ralston, 2011) . We defined that amoebae kill human 31 cells via trogocytosis (trogo-: nibble) (Ralston, 2014) . Amoebae attach to human cells and then 32 physically extract "bites" of human cell membrane, cytoplasm and organelles, which eventually 33 leads to human cell death. Amoebic trogocytosis requires engagement of the Gal/GalNAc lectin, 34 actin rearrangements, PI3K and EhC2PK signaling (Ralston, 2014) . Amoebic trogocytosis is 35 necessary for invasion of ex vivo intestinal tissue, underlining its relevance to pathogenesis 36 (Ralston, 2014) . Trogocytosis might be evolutionarily-conserved (Ralston, 2015) , therefore, 37 studying this process in E. histolytica may give insight into eukaryotic trogocytosis, in addition 38 to a better understanding of the pathogenesis of amoebiasis. 39 for cell death assays that are accurate, practical and that can be applied to a variety of human cell 41 types. Assaying human cell killing by E. histolytica is inherently challenging since readouts must 42 specifically measure the viability of the human cells when they are mixed together with 43 amoebae. For the greatest utility, assays must directly measure human cell viability, and readouts 44 must be quantitative. While amoebae can kill essentially any human cell type (Ravdin, 1980b) , 45 most studies have focused on either monolayers or suspension cultures, but not both, since they 46 are typically not amenable to the same assays. Thus, there is a need for flexible assays that can 47 be applied to both monolayers and suspension cells. Although previously used assays have been 48 important in advancing understanding of cell killing by amoebae, it is important to recognize 49 their limitations and to develop new assays as newer technologies become available. 50
Assays that have been used can be broken down into membrane permeabilization, 51 monolayer disruption, and apoptosis assays. Membrane permeabilization assays detect 52 intracellular components that are released into the culture supernatant by dead cells. In these 53 assays, amoebae are co-incubated with human cells, and the supernatant is measured. There are 54 some technical and practical limitations to the lactate dehydrogenase (LDH) release and 55
Chromium-51 ( 51 Cr) release assays that have been used. LDH assays (e.g., Li, 1994, Marie, 56 2012) generally do not directly measure LDH and instead use the NAD cofactor to catalyze a 57 reporter reaction (Riss, 2019) . This means that other enzymatic activities in the culture 58 supernatant that also use NAD as a cofactor can be problematic. By contrast, the 51 Cr release 59 assay specifically measures host cell lysis, since in this assay, host cells are pre-labeled with 60 51 Cr, and after incubation with amoebae, 51 Cr in the culture supernatant is measured (e.g., Saffer, 61 radioisotope. 63
Monolayer disruption assays have been used in many studies, but the major limitation is 64 that monolayer disruption cannot be directly attributed to cell killing since amoebic cysteine 65 protease activity disrupts monolayers (Tillack, 2006) . In monolayer disruption assays, amoebae 66 are incubated with host cell monolayers, and after washing, the remaining cells are stained with 67 methylene blue (e.g., Bracha, 1984 , Teixeira, 2012 . The amount of methylene blue is compared 68 to control monolayers that were incubated without amoebae, to infer how many cells have been 69 released. Trypan blue staining has also been used to stain dead cells remaining in the monolayer 70 (e.g., Ravdin, 1985 , Bracha, 1999 . However, since amoebic proteases cause disruption of 71 monolayers (Tillack, 2006), neither version of this assay directly measures cell killing. 72
Finally, apoptosis assays have been used to study cell killing by amoebae (Seydel, 1998 , 73 Huston, 2001 . In these assays, care must be taken to include controls that ensure the readout is 74 specific to apoptosis. For example, DNA laddering can occur in other modes of cell death 75 besides canonical apoptosis, and thus is not indicative of apoptotic cell death (Kroemer, 2008) . 76
As another example, annexin V staining to detect exposed phosphatidylserine must be combined 77 with cell permeability stains like propidium iodide, in order to ensure that phosphatidylserine 78 exposure is not simply the result of membrane damage. Notably, phosphatidylserine exposure is 79 not a universal feature of apoptosis (Galluzzi, 2018) . It is also important to note that apoptosis 80 assays capture markers of apoptosis in dying cells, which differs from other cell death assays that 81 measure cell death after it has occurred. Notably, in some cases, apoptosis can be reversed 82 (Tang, 2012). Thus, cell death is inferred by these assays, but not directly measured. 83
To enable quantitative cell death measurements, we previously developed an assay using 84 imaging flow cytometry (Ralston, 2014) . In this assay, amoebae and human cells are 85 fluorescently labeled, allowing for trogocytosis to be directly measured, and Live/Dead Violet is 86 used to stain dead (permeable) cells (Ralston, 2014 , Gilmartin, 2017 , Miller, 2019 . This assay 87 allows for automated analysis of thousands of images per sample, but is limited in practicality 88 since imaging flow cytometers are not widely available. This assay is more easily applied to 89 study suspension cells, since cells must be in suspension during image acquisition; thus, imaging 90 flow cytometry is limited in flexibility. 91
To address the limitations in practicality and flexibility of existing cell death assays, here 92 we developed two complementary high-throughput assays for human cell death. We show that 93
CellTiterGlo, a luminescent readout for cellular ATP levels, can be used as a proxy for human 94 cell viability. We also develop a confocal microscopy-based assay with fluorescent stains to 95 quantitatively differentiate live and dead human cells. Both assays are simple and inexpensive, 96 and they can be used with suspension and adherent human cell types. was added to each well, using a multichannel pipette. Plates were then incubated at 25°C for 10 137 minutes, with rocking, and then luminescence was detected using a 1 second exposure on a plate 138 reader (PerkinElmer 2030 Victor). Two wells for each condition were averaged to generate one 139 value per condition, and at least three experiments were performed independently on different For experiments using Caco-2 cells, 18-24 hours prior to performing the experiment, 100 144 µL of Caco-2 cells were plated in to three 96-well plates (Corning 3603) at a concentration of 145 2.6x10 5 cells/mL. On the day of the CellTiterGlo assay, wells containing Caco-2 cells were 146 gently washed with 200 µL of fresh TYI, twice. Amoebae were washed in fresh TYI media and 147 resuspended to 2.6x10 4 cells/mL. 100 µL of amoebae were added to wells containing Caco-2 148 cells to create an approximate co-incubation ratio of 1 amoeba: 10 Caco-2 cells. Plates were 149 incubated and treated with CellTiterGlo as described above. Three wells of amoebae alone, six 150 wells of Caco-2 cells alone, and six wells of co-incubated samples were averaged to obtain one 151 value per condition, and three experiments were performed independently on different days. 152
Dual-Stain Microscopy Assay 153
For experiments using Jurkat cells, amoebae were washed in fresh TYI media and pre-154 treated with 20 nM Cytochalasin D from Zygosporium mansonii (Sigma Aldrich) or an 155 equivalent volume of DMSO for 1 hour at 35°C. Cytochalasin D, or DMSO, was maintained at 156 the same concentration when amoebae were subsequently co-incubated with Jurkat cells. Jurkat 157 cells were pre-labeled with Hoechst 33342 (Invitrogen) at 5 µg/ml for 30 minutes at 37°C. For experiments using Caco-2 cells, Caco-2 cells were cultured on collagen-coated (5 171 µg/cm 2 Collagen I Rat Tail, Gibco) glass bottom petri dishes containing a N° 1.5 coverglass 172 (MatTek). Experiments were performed when cells were ~80% confluent. Caco-2 cells were pre-173 labeled by incubation in 2 mL of M199S containing Hoechst 33342 at 5 µg/ml for 30 minutes at 174 37°C. Amoebae and Caco-2 cells were then washed in M199S. Amoebae were resuspended to 175 1x10 5 cells/mL in M199S containing 20 nM SYTOX green, and 2 mL of amoebae were then 176 added to each plate containing Caco-2 cells. Plates were then incubated at 35°C. Cells were 177 imaged using a stage warmer set to 35°C on an Olympus FV1000 laser point-scanning confocal 178 microscope. 179
Statistical Analysis 180
GraphPad Prism was used to calculate best fit line and R 2 values, and for student's 181 Therefore, we concluded that human cell killing by amoebae can be quantitatively measured 202 using CellTiterGlo. 203
We next asked whether this assay was sensitive to conditions that inhibit human cell 204 killing by amoebae. Trogocytosis by E. histolytica requires actin rearrangements and is inhibited 205 by treatment with cytochalasin D (Ralston, 2014) . Therefore, cytochalasin D-treated or DMSO 206 control-treated amoebae were co-incubated with Jurkat cells, and cell viability was measured 207
using CellTiterGlo ( Fig. 2A -2B ). Cytochalasin D-treated amoebae were significantly less able 208 to kill human cells, as seen by the increased CellTiterGlo signal compared to control amoebae 209 ( Fig. 2A -2B ). For human cells or amoebae incubated alone, cytochalasin D treatment did not 210 affect viability (Fig. S2A ). We next tested if CellTiterGlo was sensitive to inhibition of the 211 amoeba surface Gal/GalNAc lectin. Amoeba must attach to human cells in order to kill them, 212 and this attachment is mediated by the amoebic GalNAc lectin (Petri, 2002) . Galactose-treated 213 amoebae were significantly less able to kill human cells, compared to control mannose-treated 214 amoebae ( Fig. 2C, S2B ). Finally, we tested knockdown mutant amoebae deficient in a rhomboid 215 protease, EhRom1, which has a characterized role in attachment to human cells (Baxt, 2008, 216 Baxt, 2010). There was no significant difference in the cell killing ability between EhRom1 217 knockdown mutants and vector control amoebae ( Fig. 2D, S2C ). This is consistent with the lack 218 of a trogocytosis defect in EhRom1 mutants (Miller, 2019) . Taken together, we concluded that 219 the CellTiterGlo assay is sensitive to the inhibition of human cell killing by amoebae. 220
We next sought to extend this assay to other human cell types, since many assays for cell 221 killing are difficult to adapt to both suspension and monolayer cells. Therefore, we adapted the 222 We next developed a microscopy-based assay to directly measure human cell killing by 230
amoebae. Since human cell nuclei are not internalized during amoebic trogocytosis (Ralston, 231 human cells. Human cell nuclei were pre-labeled with Hoechst. During co-incubation, SYTOX 233 green was present in the media. SYTOX green is a nucleic acid stain that is excluded by living 234 cells, but is taken up by dead cells because they have permeable membranes. Thus, live human 235 cells are labeled only by Hoechst, while dead human cells are dual-labeled by both Hoechst and 236 SYTOX green (Supplemental Video 1). To test this dual-stain assay, cytochalasin D treatment 237 was used to inhibit amoebic trogocytosis. Amoebae were treated with cytochalasin D or DMSO, 238 and co-incubated with human Jurkat T cells (Fig. 4A ). Cytochalasin D-treated amoebae killed 239 less than 2% of Jurkat cells in 60 minutes (Fig. 4B ). By comparison, control amoebae killed 40% 240 of Jurkat cells in 60 minutes. This assay provides a quantitative readout for cell killing, and it is 241 robust enough to be amenable to imaging large fields of cells at low magnification (Fig. 4C) . 242
Finally, this dual-stain assay can be applied to Caco-2 epithelial cells ( Fig. 5 
and Supplemental 243
Videos 2 -3), demonstrating that it is versatile with respect to human cell types. 244 assay allows for direct visualization of human cell death with fluorescent stains. These assays 249 complement the currently available cell death assays and bring their own unique strengths and 250
weaknesses. 251
The CellTiterGlo assay is simple and practical. Only a plate reader is required for the 252 readout. The assay requires few manipulations and no washing steps; CellTiterGlo solution is 253 added directly to cells, and after a brief incubation, luminescence is measured on a plate reader. 254
Since this assay is robust and requires very few steps, the procedure is amenable to high 255 throughput screening. Indeed, CellTiterGlo has previously been used in a high throughput screen 256 for drugs that kill E. histolytica (Debnath, 2012). The limitation of this assay is that it does not 257 directly measure human cell death. Because human cells greatly outnumber amoebae in this 258 assay, they contribute the majority of the ATP to the readout, and thus, a decrease in 259 luminescence can be inferred to represent human cell death. Also, similar to the limitations of 260 apoptosis assays, ATP levels are correlated with dying cells, but do not clearly define the "point 261 of no return" when a cell is by definition, dead (Leist, 1997, Bonora, 2012). The depletion of 262 ATP below a threshold, combined with redox alterations, has been proposed to mark the "point 263 of no return" (Galluzzi, 2015), however, it would be difficult to infer from an assay like 264
CellTiterGlo that the level of ATP has definitively crossed a threshold. However, the major 265 strengths of this assay are the simplicity and adaptability to high throughput approaches. This is 266 an area where none of the existing cell death assays are useful. Thus, we propose that this assay 267 is most useful for initial screening of mutants or candidate inhibitors. Finally, since monolayers 268 can be grown directly in the plates used for this assay, it is easily adaptable to both monolayers 269 and suspension cells. 270
The dual-stain microscopy-based cell death assay is also simple and practical. We used 271 confocal microscopy for imaging, but this is not necessary, as widefield fluorescence 272 microscopes can also be used. The major strength of this assay is that it directly measures human 273 cell death. Dead cells are labeled, thus human cell death can be directly quantified within a 274 mixture of human cells and amoebae. Moreover, the readout for cell death in this assay is loss of 275 membrane integrity, which is a direct marker of cells that are dead (Kroemer, 2008). Thus, this 276 assay, together with the imaging flow cytometry assay that we developed (Ralston, 2014) , 277
represents the most direct assays available for human cell killing for E. histolytica. The dual-278 stain assay is more practical and easy to apply, since imaging flow cytometers are not widely 279 available. Like imaging flow cytometry, the dual-stain assay can be applied to medium 280 throughput approaches, as it could be performed by using cells in plates and by imaging on high 281 content screening microscopes. The limitation of this assay is that the readout is not inherently 282 quantitative, and requires counting of labeled cell nuclei. We did not develop automated image 283 analysis, but this would be possible, and would ensure that the readout is unbiased and efficient. 284
Because both stains label the same cellular feature, the nucleus, automated image analysis should 285 be particularly robust. Finally, like the CellTiterGlo assay, the dual-stain microscopy assay is 286 amenable to both monolayer and suspension cell cultures. 287
Together, these assays expand the repertoire of available tools for studying human cell 288 killing by E. histolytica. They are particularly simple and practical, and thus we believe they are 289 suitable for wide application. These assays also pave the way for high-throughput studies. Since 290 cell killing by E. histolytica is likely to underlie disease pathogenesis, these tools are expected to 291 allow for an improved understanding of the mechanism of disease, and may be applicable to the 292 development of new therapeutics. 293
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